Home › Funds › Omega Fund Management, LLC › BBNX

Omega Fund Management, LLC position in BBNX

BETA BIONICS INC · Health Care

Omega Fund Management, LLC reported holding 962,010 shares of BBNX (BETA BIONICS INC) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 14.59% of its reported portfolio and ranking #3 among its reported holdings. Omega Fund Management, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)962.01K sh
Reported value held$18.26M
Portfolio Weight14.59%
First reportedQ1 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's BBNX position evolved

Omega Fund Management, LLC first disclosed a stake in BBNX in Q1 2025 at 1,988,287 shares (US$24.3M). The position peaked in Q4 2025 at 1,316,183 shares, worth US$40.1M. Across 7 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 962,010 shares valued at US$18.3M — a reduction of -354,173 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2025 (shares fell 67% over the following quarter), a 27% trim in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.99M $24.34M New
Q2 2025 1.99M $28.95M Hold
Q3 2025 1.92M $38.15M Reduce
Q4 2025 1.32M $40.10M Reduce
Q1 2026 1.32M $13.19M Hold
Q2 2026 1.32M $20.62M Hold
Q3 2026 962.01K $18.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBNX and 13F data

BBNX (BETA BIONICS INC) is a Health Care company. 55 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$133.7M), Sands Capital Alternatives, LLC (US$75.9M), Soleus Capital Management, L.P. (US$68.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBNX

All BBNX fund holders →

FAQ

How long has Omega Fund Management, LLC held BBNX?

Omega Fund Management, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Omega Fund Management, LLC's current position in BBNX?

As of Q3 2026, Omega Fund Management, LLC holds 962.01K shares of BBNX (BETA BIONICS INC), valued at $18.26M, representing 14.59% of its reported portfolio and ranking #3.

Has Omega Fund Management, LLC been buying or selling BBNX?

In the latest 13F filing (Q3 2026), Omega Fund Management, LLC reduced its position in BBNX. The position peaked in Q4 2025 at 1.32M shares.

Which other funds hold BBNX?

Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.